ISSN 2490-3329 (Print)
ISSN 2303-7954 (Online)

Volume 49, Issue 2, Article 4

(Scr Med 2018:49:99-104)
ORIGINAL SCIENTIFIC ARTICLE

Importance of Selection a Method of Reconstruction of Digestive Continuity After Gastrectomy

Jovan Ćulum1, Nebojša Trkulja3, Dmitar Travar5, Zoran Aničić2, Jugoslav Ðeri2, Goran Janjić2, Velimir Škrbić2, Aleksandar Guzijan4, Davor Grahovac4

1 Clinic “S-tetik” Banja Luka, RS, BiH, Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina
2 Clinic for General and Abdominal Surgery, University Clinical Center of the Republic of Srpska, Banja Luka, RS, BiH, Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina
3 Clinic for General and Abdominal Surgery, University Clinical Center of the Republic of Srpska, Banja Luka, RS, BiH
4 Mammal center, University Clinical Center of the Republic of Srpska, Banja Luka, RS, BiH, Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina
5 Clinic for Otorhinolaryngology, University Clinical Center of the Republic of Srpska, Banja Luka, RS, BiH, Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina

 

DOI 10.7251/SCMED1802099C
UDC 616.33-005.1-089.87
COBISS.RS-ID 7836952

 

ABSTRACT

Introduction: Gastrectomy is one of the most common surgical methods for the treatment of gastric cancer, which basically destroys the mechanism and digestion chemistry. Reconstruction after gastrectomy attempts to optimize the antireflux and nutritive component of the postgastrectomic syndrome.

Objective: To determine which reconstructive method after gastrectomy has the optimal synthesis of antireflux and nutritional components.

Patients and Methods: 111 patients were treated for gastric malignancies at the Surgical Clinic of the University Clinical Center in Banja Luka, which were operated with the intention of achieving curability.

Results: Based on Fisher’s exact probability test there is no statistically significant difference (p> 0.05) in mortality compared to the restoration of digestive continuity after gastrectomy. Reflux oesophagitis is the dominant modality of morbidity in omega-loop reconstruction (p <0.05). There is no statistically significant difference (p> 0.05) in late dumping syndrome in patients relative to individual gastric substitution options. In the Hunt-Lawrence-Rodino pouch reconstruction option, there is no statistically significant difference (p> 0.05) in the participation of individual modalities of meal quantity in relation to the condition before the disease or the modality of the nutritional status. .

Conclusion: The results indicate the antireflux component of reconstruction Roux en Y and the advantage of the nutritive component in the loop modification (the creation of the Hunt-Lawrence-Rodino pouch).

Key words: gastric cancer, gastrectomy, methods of reconstruction, postoperative morbidity

 

Pdf version of article

 

 

References:

1. Coburn N, Seevaratnam R, Paszat L, Helyer L, Law C, Swallow C, et al. Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg 2014;259:102-8.
2. Bo T, Peiwu Y, Feng Q, Yongliang Z, Yan S, Yingxue H, et al. Laparoscopy-assisted vs. open total gastrectomy for advanced gastric cancer: long-term outcomes and technical aspects of a case-control study. J Gastrointest Surg 2013;17:1202-8.
3. Shin D, Park SS. Clinical importance and surgical decision-making regarding proximal resection margin for gastric cancer. World J Gastrointest Oncol 2013;5:4-11.
4. Squires MH 3rd, Kooby DA, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, et al. Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol 2015;22:1243-51.
5. Brar S, Law C, McLeod R, Helyer L, Swallow C, Paszat L, et al. Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg 2013;217:347-57.
6. Hirao M, Takiguchi S, Imamura H, Yamamoto K, Kurokawa Y, Fujita J, et al. Comparison of Billroth I and Roux-en-Y reconstruction after distal gastrectomy for gastric cancer: one-year postoperative effects assessed by a multi-institutional RCT. Ann Surg Oncol 2013;20:1591-7.
7. Kurita N, Miyata H, Gotoh M, Shimada M, Imura S, Kimura W, et al. Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg 2015;262:295-303.
8. Avery K, Hughes R, McNair A, Alderson D, Barham P, Blazeby J. Health-related quality of life and survival in the 2 years after surgery for gastric cancer. Eur J Surg Oncol. 2010;36(2):148–54.
9. Karanicolas PJ, Bickenbach K, Jayaraman S, Pusic AL, Coit DG, Guyatt GH, et al. Measurement and interpretation of patient-reported outcomes in surgery: an opportunity for improvement. J Gastrointest Surg 2011;15(4):682–9.
10. King MT, Fayers PM. Making quality-of-life results more meaningful for clinicians. Lancet 2008;371:709–10.
11. Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg 2011;35(2):357–64.
12. Lee SS, Chung HY, Yu W. Quality of life of long-term survivors after a distal subtotal gastrectomy. Cancer Res Treat 2010;42(3):130–4.
13. Nakamura M, Hosoya Y, Yano M, Doki Y, Miyashiro I, Kurashina K, et al. Extent of gastric resection impacts patient quality of life: the Dysfunction After Upper Gastrointestinal Surgery for Cancer (DAUGS32) scoring system. Ann Surg Oncol 2011;18(2):314–20.
14. Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer 2001;37(8):966–71.
15. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg 1995;82:216–22.
16. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993;11:570–579.
17. McCall MD, Graham PJ, Bathe OF. Quality of life: a critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol 2016;22(3):1101–13.
18. Climent M, Munarriz M, Blazeby JM, Dorcaratto D, Ramon JM, Carrera MJ. Weight loss and quality of life in patients surviving 2 years after gastric cancer resection. Eur J Surg Oncol 2017;43(7):1337-43.
19. Munene G, Francis W, Garland SN, Pelletier G, Mac KLA, Bathe OF. The quality of life trajectory of resected gastric cancer. J Surg Oncol 2012;105:337–41.
20. Watanabe M, Mine S, Nishida K, Kurogochi T, Okamura A, Imamura Y. Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy. Gen Thorac Cardiovasc Surg 2016;64(8):457–63.
21. Nakamura M, Hosoya Y, Umeshita K, Yano M, Doki Y, Miyashiro I, et al. Postoperative quality of life: development and validation of the “Dysfunction After Upper Gastrointestinal Surgery” scoring system. J Am Coll Surg 2011;213:508–14.
22. Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer 2012;15(2):198–205.


Corresponding author:
Jovan Ćulum
e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Manuscript received: July 9th, 2018
Manuscript accepted: November 7th, 2018